FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Ravi Salgia

Research Profile

Disorders

Chemicals & Drugs

Physiology

Living Beings

Mouse

Phenomena

Phosphorylation

Anatomy

Co-author Network

Publications

TOP 3
Sherven Sharma; Maie St John; Li Zhu; Michael Davoodi; Marni Harris-White; Jay M Lee; Ravi Salgia; Steven Dubinett
TLR3 agonists and proinflammatory antitumor activities.
Ahad A Sadiq; Ravi Salgia
MET as a possible target for non-small-cell lung cancer.
Rimas V Lukas; Monica Malec; Kourosh Rezania; Ravi Salgia
Teaching Video NeuroImages: myokymia and nerve hyperexcitability as components of Morvan syndrome due to malignant thymoma.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Ravi Salgia (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Sherven Sharma; Maie St John; Li Zhu; Michael Davoodi; Marni Harris-White; Jay M Lee; Ravi Salgia; Steven Dubinett
TLR3 agonists and proinflammatory antitumor activities.
Expert opinion on therapeutic targets 2013;17(5):481-3.
2013: Ahad A Sadiq; Ravi Salgia
MET as a possible target for non-small-cell lung cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2013;31(8):1089-96.
2013: Rimas V Lukas; Monica Malec; Kourosh Rezania; Ravi Salgia
Teaching Video NeuroImages: myokymia and nerve hyperexcitability as components of Morvan syndrome due to malignant thymoma.
Neurology 2013;80(5):e55.
2013: Yulia Ephstein; Joe G. N. Garcia; Weiguo Chen; Steven M Dudek; Prasad Vk Kanteti; Ravi Salgia; Patrick A Singleton; Lichun Wang; Jeffrey Jacobson
Critical role of S1PR1 and integrin β4 in HGF/c-Met-mediated increases in vascular integrity.
The Journal of biological chemistry 2013;288(4):2191-200.
2013: Victoria M Villaflor; Ravi Salgia
Targeted agents in non-small cell lung cancer therapy: What is there on the horizon?
Journal of carcinogenesis 2013;12():7.
2013: Rifat Hasina; Aliya N Husain; Elizabeth Hyjek; Geetanjali Kanade; Dorothy Kane; Rajani Kanteti; Ichiro Kawada; Xiuqing Li; Mark W Lingen; Ren Liu; Nathan Mollberg; Jeffery Mueller; Karun Mutreja; Vidya Nallasura; Mitchell C Posner; Yutaka Shimada; Mosmi Surati; Lyuba Varticovski; Victoria M Villaflor; Everett E Vokes; Irving Waxman; Soheil Yala; Yue Zhou; Kenneth S Cohen; Essam El Hashani; Benjamin D Ferguson; Mark K Ferguson; Parkash Gill; Ravi Salgia
Critical role for the receptor tyrosine kinase EPHB4 in esophageal cancers.
Cancer research 2013;73(1):184-94.
2012: Ahad A Sadiq; Ravi Salgia
Inhibition of MET receptor tyrosine kinase and its ligand hepatocyte growth factor.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2012;7(16 Suppl 5):S372-4.
2012: Sherven Sharma; Steven Dubinett; Ravi Salgia
CD14(+)S100A9(+) myeloid-derived suppressor cells portend decreased survival in patients with advanced lung cancer.
American journal of respiratory and critical care medicine 2012;186(10):940-1.
2012: D Ross Camidge; Jeffrey W Clark; Daniel B Costa; Jeffrey A Engelman; Panagiotis Fidias; Stephen B Fox; Leena Gandhi; A John Iafrate; Pasi A Janne; Dong-Wan Kim; Eunice L Kwak; Patricia M LoRusso; Sai-Hong I Ou; Gregory J Riely; Katherine Ruffner; Ravi Salgia; Geoffrey I Shapiro; Benjamin Solomon; Patricia Stephenson; Yiyun Tang; Marileila Varella-Garcia; Keith Wilner; Yung-Jue Bang; Alice T Shaw
Activity and safety of crizotinib in patients with ALK-positive non-small-cell lung cancer: updated results from a phase 1 study.
The lancet oncology 2012;13(10):1011-9.
2012: Nathan M Mollberg; Ravi Salgia; Aliyah N Husain; Hedy L Kindler; Yalini Vigneswaran; Cynthia Warnes; Wickii T Vigneswaran
Quality of life after radical pleurectomy decortication for malignant pleural mesothelioma.
The Annals of thoracic surgery 2012;94(4):1086-92.
2012: Andres Morales La Madrid; Nicholas Campbell; Susan L Cohn; Sonali Smith; Ravi Salgia
Targeting ALK: a promising strategy for the treatment of non-small cell lung cancer, non-Hodgkin's lymphoma, and neuroblastoma.
Targeted oncology 2012;7(3):199-210.
2012: Rajani Kanteti; Soundararajan Krishnaswamy; Yi-Hung Carol Tan; Maria Tretiakova; Everett E Vokes; Daniel Catenacci; Gustavo Cervantes; Essam EL-Hashani; Heather Huet; Aliya N Husain; Ravi Salgia
Differential expression of RON in small and non-small cell lung cancers.
Genes, chromosomes & cancer 2012;51(9):841-51.
2012: Michael T Jaklitsch; James R Jett; Shaf Keshavjee; Heber MacMahon; James L Mulshine; Reginald F Munden; Ravi Salgia; Gary M Strauss; John H M Austin; John K Field; Francine L Jacobson; Scott J Swanson; William D Travis; David J Sugarbaker
The American Association for Thoracic Surgery guidelines for lung cancer screening using low-dose computed tomography scans for lung cancer survivors and other high-risk groups.
The Journal of thoracic and cardiovascular surgery 2012;144(1):33-8.
2012: Francine L Jacobson; John H M Austin; John K Field; James R Jett; Shaf Keshavjee; Heber MacMahon; James L Mulshine; Reginald F Munden; Ravi Salgia; Gary M Strauss; David J Sugarbaker; Scott J Swanson; William D Travis; Michael T Jaklitsch
Development of The American Association for Thoracic Surgery guidelines for low-dose computed tomography scans to screen for lung cancer in North America: recommendations of The American Association for Thoracic Surgery Task Force for Lung Cancer Screening and Surveillance.
The Journal of thoracic and cardiovascular surgery 2012;144(1):25-32.
2012: Maria C Pietanza; Katharine A Price; Gregory J Riely; Kendrith M Rowland; Ravi Salgia; Margaret Tonda; Michael S Wertheim; Christopher G Azzoli; Jan H Beumer; Afshin Dowlati; Shirish M Gadgeel; Mark G Kris; Lee M Krug; Thomas J Lynch; Vincent A Miller; Ben Mitchell; Naiyer A Rizvi
Phase II study of the multitargeted tyrosine kinase inhibitor XL647 in patients with non-small-cell lung cancer.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2012;7(5):856-65.
2012: Jalees Rehman; Ravi Salgia; Peter T Toth; Christian Wietholt; Hannah J Zhang; Yanmin Zhang; Zhigang Hong; Aliya N Husain; Glenn Marsboom; Stephen L Archer
Inhibition of mitochondrial fission prevents cell cycle progression in lung cancer.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2012;26(5):2175-86.
2012: Frances E Lennon; Bolot Mambetsariev; Tamara Mirzapoiazova; Jonathan Moss; Ravi Salgia; Patrick A Singleton
Overexpression of the μ-opioid receptor in human non-small cell lung cancer promotes Akt and mTOR activation, tumor growth, and metastasis.
Anesthesiology 2012;116(4):857-67.
2012: Ezra E W Cohen; Leonardo Faoro; Feng Gao; Ramaswamy Govindan; Theodore Karrison; Mark F. Kozloff; Ravi Salgia; Janakiraman Subramanian; Livia Szeto; Everett E Vokes
Targeted and cytotoxic therapy in coordinated sequence (TACTICS): erlotinib, bevacizumab, and standard chemotherapy for non-small-cell lung cancer, a phase II trial.
Clinical lung cancer 2012;13(2):123-8.
2012: Michael D Hasselle; Philip C Hoffman; Kyle E Rusthoven; Steven J Chmura; Philip P Connell; Daniel W Golden; Daniel J Haraf; Ravi Salgia; Niket Shah; Victoria M Villaflor; Everett E Vokes; Ralph R Weichselbaum; Joseph K Salama
Hypofractionated image-guided radiation therapy for patients with limited volume metastatic non-small cell lung cancer.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2012;7(2):376-81.
2012: George B Carey; Paul Dave; Thomas Hensing; Aliya N Husain; Archana Kanteti; Stephanie Kazantsev; Hedy L Kindler; Ravi Madduri; Brigitte Raumann; Cleo E Rolle; Ahad Sadiq; Adam Starkey; Mosmi Surati; Wickii T Vigneswaran; Everett E Vokes; Samuel G Armato; Neil Bahroos; Ravi Salgia
Utilisation of a thoracic oncology database to capture radiological and pathological images for evaluation of response to chemotherapy in patients with malignant pleural mesothelioma.
BMJ open 2012;2(5):.
2012: Nathan M Mollberg; Nigel M Parsad; Ravi Salgia; William F Sensakovic; Jonathan Silverstein; Janani Vigneswaran; Samuel G Armato; Hedy L Kindler; Wickii T Vigneswaran
Three-dimensional stereoscopic volume rendering of malignant pleural mesothelioma.
International surgery 2012;97(1):65-70.
2012: Satish Kalari; Archana Kanteti; Prasad Kanteti; Rajani Kanteti; Hedy L Kindler; Wenli Ma; Nagabhushan Moolky; Evgeny Berdyshev; Donghong He; Aliya N Husain; Srikanth Pendyala; Cleo Rolle; Ravi Salgia; Viswanathan Natarajan
Sphingosine kinase 1 is required for mesothelioma cell proliferation: role of histone acetylation.
PloS one 2012;7(9):e45330.
2012: Fang-Yi Lo; Suvobroto Nandi; Ravi Salgia; Fang-Yu Tsai; I-Shou Chang; Jer-Wei Chang; Yann-Jang Chen; Han-Shui Hsu; Shiu-Feng Kathy Huang; Shih Sheng Jiang; Rajani Kanteti; Yi-Ching Wang
The database of chromosome imbalance regions and genes resided in lung cancer from Asian and Caucasian identified by array-comparative genomic hybridization.
BMC cancer 2012;12():235.
2012: Lisandra West; Jeff Shrager; George R Simon; Smruti J Vidwans; Raphael Bueno; Nicholas P Campbell; Phillip A Dennis; Gregory A Otterson; Ravi Salgia
A novel classification of lung cancer into molecular subtypes.
PloS one 2012;7(2):e31906.
2012: Shengri Liao; Bill C Penney; Daniel E Appelbaum; Chin-Tu Chen; Sheng Chen; Rony Kampalath; Ravi Salgia; Ming-Chi Shih; Naoko Shimada; Cassie A Simon; Kenji Suzuki; Kristen Wroblewski; Hao Zhang; Yonglin Pu
Prognostic value of metabolic tumor burden on 18F-FDG PET in nonsurgical patients with non-small cell lung cancer.
European journal of nuclear medicine and molecular imaging 2012;39(1):27-38.
2011: Daniel V T Catenacci; Les Henderson; Premal Patel; Amy Peterson; Shu-Yuan Xiao; Robert L Yauch; Priti Hegde; Ajay Pandita; Jiping Zha; Ravi Salgia
Durable complete response of metastatic gastric cancer with anti-Met therapy followed by resistance at recurrence.
Cancer discovery 2011;1(7):573-9.
2011: Mosmi Surati; Premal Patel; Amy Peterson; Ravi Salgia
Role of MetMAb (OA-5D5) in c-MET active lung malignancies.
Expert opinion on biological therapy 2011;11(12):1655-62.
2011: D Shumway; W T Vigneswaren; V Villaflor; Ravi Salgia; Arif Y Shaikh; Philip P Connell; K Corbin; Mark K Ferguson; Daniel J Haraf; P Hoffman; R M Malik; Joseph K Salama
Pathologic response rates following definitive dose image-guided chemoradiotherapy and resection for locally advanced non-small cell lung cancer.
Lung cancer (Amsterdam, Netherlands) 2011;74(3):446-50.
2011: Fang-Yi Lo; Ravi Salgia; Yi-Hung Carol Tan; Hung-Chi Cheng; Yi-Ching Wang
An E3 ubiquitin ligase: c-Cbl: a new therapeutic target of lung cancer.
Cancer 2011;117(23):5344-50.
2011: Ahad A Sadiq; Daniel M Geynisman; Ravi Salgia
Inhibition of MET receptor tyrosine kinase and its ligand hepatocyte growth factor.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2011;6(11 Suppl 4):S1810-1.
2011: Alice T Shaw; Benjamin J Solomon; Yiyun Tang; Marileila Varella-Garcia; Keith D Wilner; Beow Y Yeap; Yung-Jue Bang; Mohit Butaney; Jeffrey W Clark; Daniel B Costa; Robert C Doebele; Jeffrey A Engelman; Justin Gainor; A John Iafrate; Kimary Kulig; Eunice L Kwak; ROBERT G MAKI; Sai-Hong I Ou; Gregory J Riely; Ravi Salgia; Paulina Selaru; Geoffrey I Shapiro; D Ross Camidge
Effect of crizotinib on overall survival in patients with advanced non-small-cell lung cancer harbouring ALK gene rearrangement: a retrospective analysis.
The lancet oncology 2011;12(11):1004-12.
2011: Suresh S Ramalingam; Karen Reckamp; Ravi Salgia; Miguel Villalona-Calero; Everett E Vokes; John J Wright; Chandra P Belani; Angela M Davies; Martin J Edelman; Barbara Gitlitz; Primo Lara; Jeffrey Longmate; David R Gandara
Bortezomib for patients with advanced-stage bronchioloalveolar carcinoma: a California Cancer Consortium Phase II study (NCI 7003).
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2011;6(10):1741-5.
2011: Jing Zhao; Mintao Zhong; Evgeny Berdyshev; Donghong He; Andrew James Morris; Viswanathan Natarajan; Ravi Salgia; Susan S Smyth; Yutong Zhao
Autotaxin induces lung epithelial cell migration through lysoPLD activity-dependent and -independent pathways.
The Biochemical journal 2011;439(1):45-55.
2011: Ravi Salgia
Prognostic significance of angiogenesis and angiogenic growth factors in nonsmall cell lung cancer.
Cancer 2011;117(17):3889-99.
2011: Dylan M Glubb; Fred R Hirsch; Kurt Ballmer-Hofer; Elisa Cerri; Peixian Chen; Soma Das; Rafal Dziadziuszko; Alexandra Giese; Jacek Jassem; Mark W Lingen; Osman Mirza; Witold Rzyman; Ravi Salgia; Emma E Thompson; Wei Zhang; Federico Innocenti
Novel functional germline variants in the VEGF receptor 2 gene and their effect on gene expression and microvessel density in lung cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2011;17(16):5257-67.
2011: Eng Huat Tan; Raymond Thertulien; Michael Wertheim; James Chih-Hsin Yang; Benjamin Besse; Dawn M Carlson; David R Gandara; Glenwood D Goss; Neeraj Gupta; Nasser H Hanna; Thomas A Hensing; Christa Lee; Julien Mazieres; Rajendra Pradhan; Jiang Qian; Qin Qin; Justin L Ricker; Ravi Salgia; Frank Scappaticci; Ross Soo
Phase 2 trial of Linifanib (ABT-869) in patients with advanced non-small cell lung cancer.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2011;6(8):1418-25.
2011: Michael T Schweizer; Rupa Mehta; Ravi Salgia; Victoria M Villaflor
Takotsubo cardiomyopathy in a patient with squamous cell esophageal carcinoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011;29(20):e598-600.
2011: Martin Sattler; Tara Gangadhar; Rifat Hasina; Mamatha M Reddy; Ravi Salgia
The role of the c-Met pathway in lung cancer and the potential for targeted therapy.
Therapeutic advances in medical oncology 2011;3(4):171-84.
2011: Razelle Kurzrock; Ranee Mehra; Thomas Müller; Forlisa Nauling; Chaan S Ng; David G Pfister; Mark J Ratain; Douglas W Ball; Ezra E W Cohen; Roger B Cohen; Arlene A Forastiere; John Frye; Robert F Gagel; David S Hong; Linda Janisch; Steven I Sherman; Lei Ye; Ravi Salgia
Activity of XL184 (Cabozantinib), an oral tyrosine kinase inhibitor, in patients with medullary thyroid cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011;29(19):2660-6.
2011: Daniel V T Catenacci; Gustavo Cervantes; Mohamed El Dinali; Essam El-Hashani; David A Frank; Tatyana A Grushko; Rifat Hasina; Les Henderson; Heather Huet; Rajani Kanteti; Theodore Karrison; Woo Ho Kim; Hedy L Kindler; Erik A Nelson; Olufunmilayo Olopade; Michele Sanicola; Tanguy Seiwert; Maria Tretiakova; Everett Vokes; Soheil Yala; Yung-Jue Bang; Johannes Brägelmann; Ravi Salgia
RON (MST1R) is a novel prognostic marker and therapeutic target for gastroesophageal adenocarcinoma.
Cancer biology & therapy 2011;12(1):9-46.
2011: Ana R Jensen; Evan T Keller; Chuanhong Liao; Viswanathan Natarajan; Gladell P Paner; Hikmat Al-Ahmadie; Gustavo M Cervantes; Jinlu Dai; Kelly Dakin-Haché; Saito Y David; Ravi Salgia; Margarit F Sievert; Peter Usatyuk; Soheil Yala; Edwin M Posadas
Fyn is downstream of the HGF/MET signaling axis and affects cellular shape and tropism in PC3 cells.
Clinical cancer research : an official journal of the American Association for Cancer Research 2011;17(10):3112-22.
2011: Sai-Hong Ignatius Ou; Ravi Salgia; Christina Siwak-Tapp; Benjamin J Solomon; Weiwei Tan; Keith D Wilner; Yung-Jue Bang; Kristin Bergethon; D Ross Camidge; James Christensen; Jeffrey W Clark; Joni Dy; Dong-Wan Kim; Eunice L Kwak; ROBERT G MAKI; A John Iafrate
Activity of crizotinib (PF02341066), a dual mesenchymal-epithelial transition (MET) and anaplastic lymphoma kinase (ALK) inhibitor, in a non-small cell lung cancer patient with de novo MET amplification.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2011;6(5):942-6.
2011: Ravi Salgia; Thomas Hensing; Nicholas Campbell; April K Salama; Michael Maitland; Philip Hoffman; Victoria Villaflor; Everett E Vokes
Personalized treatment of lung cancer.
Seminars in oncology 2011;38(2):274-83.
2011: Wanqing Liu; Lijun He; Jacqueline Ramírez; Soundararajan Krishnaswamy; Rajani Kanteti; Yi-Ching Wang; Ravi Salgia; Mark J Ratain
Functional EGFR germline polymorphisms may confer risk for EGFR somatic mutations in non-small cell lung cancer, with a predominant effect on exon 19 microdeletions.
Cancer research 2011;71(7):2423-7.
2011: Martin J Edelman; Gregory Otterson; Joseph Leach; Thomas Malpass; Ravi Salgia; Dennie Jones; Tarak D Mody; Ramaswamy Govindan
Multicenter phase II trial of Motexafin gadolinium and pemetrexed for second-line treatment in patients with non-small cell lung cancer.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2011;6(4):786-9.
2011: Biji Mathew; Frances E Lennon; Jessica Siegler; Tamara Mirzapoiazova; Nurbek Mambetsariev; Saad Sammani; Lynnette M Gerhold; Patrick J LaRiviere; Chin-Tu Chen; Joe G. N. Garcia; Ravi Salgia; Jonathan Moss; Patrick A Singleton
The novel role of the mu opioid receptor in lung cancer progression: a laboratory investigation.
Anesthesia and analgesia 2011;112(3):558-67.
2011: Mosmi Surati; Victoria Villaflor; Everett E Vokes; Qudsia Arif; Nicholas Campbell; Carley Demchuk; Leonardo Faoro; Ben Ferguson; Mark K Ferguson; Tara C Gangadhar; Rifat Hasina; Thomas A Hensing; Aliya N Husain; Rajani Kanteti; Theodore Karrison; Colin Kirchner; Thomas Krausz; Suwicha Limvorasak; Eneida A Mendonca; Suvobroto Nandi; Matthew Robinson; Cleo E Rolle; April K Salama; Ravi Salgia
Proteomic characterization of non-small cell lung cancer in a comprehensive translational thoracic oncology database.
Journal of clinical bioinformatics 2011;1(8):1-11.
2011: Sivakumar Loganathan; Rajani Kanteti; Shahid S Siddiqui; Essam El-Hashani; Maria Tretiakova; Hari Vigneswaran; Gustavo Cervantes; Viswanathan Natarajan; Aliya N Husain; Everett E Vokes; Hedy L Kindler; Ravi Salgia
Role of protein kinase C β and vascular endothelial growth factor receptor in malignant pleural mesothelioma: Therapeutic implications and the usefulness of Caenorhabditis elegans model organism.
Journal of carcinogenesis 2011;10():4.
2011: Mosmi Surati; Matthew Robinson; Suvobroto Nandi; Leonardo Faoro; Carley Demchuk; Rajani Kanteti; Benjamin Ferguson; Tara Gangadhar; Thomas Hensing; Rifat Hasina; Aliya Husain; Mark Ferguson; Theodore Karrison; Ravi Salgia
Generation of comprehensive thoracic oncology database--tool for translational research.
Journal of visualized experiments : JoVE 2011;(47):.
2011: Alexander C Mackinnon; Maria Tretiakova; Les Henderson; Rajendra G Mehta; Benjamin C Yan; Loren Joseph; Thomas Krausz; Aliya N Husain; Mary E Reid; Ravi Salgia
Paxillin expression and amplification in early lung lesions of high-risk patients, lung adenocarcinoma and metastatic disease.
Journal of clinical pathology 2011;64(1):16-24.
2010: Sai-Hong Ignatius Ou; Lyudmila Bazhenova; D Ross Camidge; Benjamin J Solomon; June Herman; Tatiana Kain; Yung-Jue Bang; Eunice L Kwak; Alice T Shaw; Ravi Salgia; ROBERT G MAKI; Jeffrey W Clark; Keith D Wilner; A John Iafrate
Rapid and dramatic radiographic and clinical response to an ALK inhibitor (crizotinib, PF02341066) in an ALK translocation-positive patient with non-small cell lung cancer.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2010;5(12):2044-6.
2010: Jie Song; Mei Li; Maria Tretiakova; Ravi Salgia; Philip T Cagle; Aliya N Husain
Expression patterns of PAX5, c-Met, and paxillin in neuroendocrine tumors of the lung.
Archives of pathology & laboratory medicine 2010;134(11):1702-5.
2010: Margret S Fernandes; Mamatha M Reddy; Nicole J Croteau; Christoph Walz; Henry Weisbach; klaus podar; Hamid Band; Martin Carroll; Andreas Reiter; Richard A Larson; Ravi Salgia; James D Griffin; Martin Sattler
Novel oncogenic mutations of CBL in human acute myeloid leukemia that activate growth and survival pathways depend on increased metabolism.
The Journal of biological chemistry 2010;285(42):32596-605.
2010: Leonardo Faoro; Patrick A Singleton; Gustavo M Cervantes; Frances E Lennon; Nicholas W Choong; Rajani Kanteti; Ben Ferguson; Aliya N Husain; Maria S Tretiakova; Nithya Ramnath; Everett E Vokes; Ravi Salgia
EphA2 mutation in lung squamous cell carcinoma promotes increased cell survival, cell invasion, focal adhesions, and mammalian target of rapamycin activation.
The Journal of biological chemistry 2010;285(24):18575-85.
2010: David S Ettinger; Robert Jotte; Paul Lorigan; Vicram Gupta; Lawrence Garbo; Carlos Alemany; Paul Conkling; David R Spigel; Arkadiusz Z Dudek; Chirag Shah; Ravi Salgia; Richard McNally; Markus F Renschler; Jennifer W Oliver
Phase II study of amrubicin as second-line therapy in patients with platinum-refractory small-cell lung cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(15):2598-603.
2010: Yoshihito D Saito; Ana R Jensen; Ravi Salgia; Edwin M Posadas
Fyn: a novel molecular target in cancer.
Cancer 2010;116(7):1629-37.
2010: Joseph B Mascarenhas; Erica L Littlejohn; Rebecca J Wolsky; Kacey P Young; Maria Nelson; Ravi Salgia; Deborah Lang
PAX3 and SOX10 activate MET receptor expression in melanoma.
Pigment cell & melanoma research 2010;23(2):225-37.
2010: Tara Gangadhar; Suvobroto Nandi; Ravi Salgia
The role of chemokine receptor CXCR4 in lung cancer.
Cancer biology & therapy 2010;9(6):409-16.
2010: Patrick A Singleton; Nurbek Mambetsariev; Frances E Lennon; Biji Mathew; Jessica H Siegler; Liliana Moreno Vinasco; Ravi Salgia; Jonathan Moss; Joe G. N. Garcia
Methylnaltrexone potentiates the anti-angiogenic effects of mTOR inhibitors.
Journal of angiogenesis research 2010;2(1):5.
2010: Ryan E Lawrence; Ravi Salgia
MET molecular mechanisms and therapies in lung cancer.
Cell adhesion & migration 2010;4(1):146-52.
2010: Yi-Hung Carol Tan; Soundararajan Krishnaswamy; Suvobroto Nandi; Rajani Kanteti; Sapana Vora; Kenan Onel; Rifat Hasina; Fang-Yi Lo; Essam El-Hashani; Gustavo Cervantes; Matthew Robinson; Han-Shui Hsu; Stephen C Kales; Stanley Lipkowitz; Theodore Karrison; Martin Sattler; Everett E Vokes; Yi-Ching Wang; Ravi Salgia
CBL is frequently altered in lung cancers: its relationship to mutations in MET and EGFR tyrosine kinases.
PloS one 2010;5(1):e8972.
2009: Mandira Ray; Ravi Salgia; Everett E Vokes
The role of EGFR inhibition in the treatment of non-small cell lung cancer.
The oncologist 2009;14(11):1116-30.
2009: Leonardo Faoro; Gustavo M Cervantes; Essam El-Hashani; Ravi Salgia
MET receptor tyrosine kinase.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2009;4(11 Suppl 3):S1064-5.
2009: Joseph B Mascarenhas; Kacey P Young; Erica L Littlejohn; Brian K Yoo; Ravi Salgia; Deborah Lang
PAX6 is expressed in pancreatic cancer and actively participates in cancer progression through activation of the MET tyrosine kinase receptor gene.
The Journal of biological chemistry 2009;284(40):27524-32.
2009: Jianbo Yang; Matthew A Price; Gui-Yuan Li; Menashe Bar-Eli; Ravi Salgia; Ramasamy Jagedeeswaran; Jennifer H Carlson; Soldano Ferrone; Eva A Turley; James B McCarthy
Melanoma proteoglycan modifies gene expression to stimulate tumor cell motility, growth, and epithelial-to-mesenchymal transition.
Cancer research 2009;69(19):7538-47.
2009: Soundararajan Krishnaswamy; Rajani Kanteti; Jonathan S Duke-Cohan; Sivakumar Loganathan; Wanqing Liu; Patrick C Ma; Martin Sattler; Patrick A Singleton; Nithya Ramnath; Federico Innocenti; Dan L Nicolae; Zheng Ouyang; Jie Liang; John Minna; Mark F. Kozloff; Mark K Ferguson; Viswanathan Natarajan; Yi-Ching Wang; Joe G. N. Garcia; Everett E Vokes; Ravi Salgia
Ethnic differences and functional analysis of MET mutations in lung cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(18):5714-23.
2009: A Singal; Michael Volk; A Waljee; Ravi Salgia; Peter Higgins; Mary A M Rogers; Jorge A Marrero
Meta-analysis: surveillance with ultrasound for early-stage hepatocellular carcinoma in patients with cirrhosis.
Alimentary pharmacology & therapeutics 2009;30(1):37-47.
2009: Ravi Salgia
Role of c-Met in cancer: emphasis on lung cancer.
Seminars in oncology 2009;36(2 Suppl 1):S52-8.
2009: Eric S Kim; Ravi Salgia
MET pathway as a therapeutic target.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2009;4(4):444-7.
2009: Tanguy Seiwert; Ramasamy Jagadeeswaran; Leonardo Faoro; Varalakshmi Janamanchi; Vidya Nallasura; Mohamed El Dinali; Soheil Yala; Rajani Kanteti; Ezra E W Cohen; Mark W Lingen; Leslie Martin; Soundararajan Krishnaswamy; Andres Klein-Szanto; James G Christensen; Everett E Vokes; Ravi Salgia
The MET receptor tyrosine kinase is a potential novel therapeutic target for head and neck squamous cell carcinoma.
Cancer research 2009;69(7):3021-31.
2009: Rajani Kanteti; Vidya Nallasura; Sivakumar Loganathan; Maria Tretiakova; Todd Kroll; Soundararajan Krishnaswamy; Leonardo Faoro; Philip Cagle; Aliya N Husain; Everett E Vokes; Deborah Lang; Ravi Salgia
PAX5 is expressed in small-cell lung cancer and positively regulates c-Met transcription.
Laboratory investigation; a journal of technical methods and pathology 2009;89(3):301-14.
2009: Nicole A Cipriani; Oyewale O Abidoye; Everett Vokes; Ravi Salgia
MET as a target for treatment of chest tumors.
Lung cancer (Amsterdam, Netherlands) 2009;63(2):169-79.
2009: Z Tang; S Jiang; R Du; E T Petri; A El-Telbany; P S O Chan; T Kijima; S Dietrich; K Matsui; M Kobayashi; S Sasada; N Okamoto; H Suzuki; K Kawahara; T Iwasaki; K Nakagawa; I Kawase; J G Christensen; T Hirashima; Balazs Halmos; Ravi Salgia; Titus Boggon; Jeffrey A Kern; P C Ma
Disruption of the EGFR E884-R958 ion pair conserved in the human kinome differentially alters signaling and inhibitor sensitivity.
Oncogene 2009;28(4):518-33.
2009: Leonardo Faoro; Gustavo M Cervantes; Ben Ferguson; Tanguy Seiwert; Soheil Yala; Wicki T Vigneswaran; Maria Westerhoff; Maria Tretiakova; Mark K Ferguson; Glaci L Moura; Aliya N Husain; Everett E Vokes; Ravi Salgia
MET/PKCbeta expression correlate with metastasis and inhibition is synergistic in lung cancer.
Journal of carcinogenesis 2009;8():15.
2009: Rajani Kanteti; Soheil Yala; Mark K Ferguson; Ravi Salgia
MET, HGF, EGFR, and PXN gene copy number in lung cancer using DNA extracts from FFPE archival samples and prognostic significance.
Journal of environmental pathology, toxicology and oncology : official organ of the International Society for Environmental Toxicology and Cancer 2009;28(2):89-98.
2009: Edwin M Posadas; Hikmat Al-Ahmadie; Victoria L Robinson; Ramasamy Jagadeeswaran; Kristen Otto; Kenneth E Kasza; Maria Tretiakov; Javed Siddiqui; Kenneth J Pienta; Walter M Stadler; Carrie W Rinker-Schaeffer; Ravi Salgia
FYN is overexpressed in human prostate cancer.
BJU international 2009;103(2):171-7.
2008: Leonardo Faoro; Joann Y Hutto; Ravi Salgia; Shady A El-Zayaty; Mark K Ferguson; Richard T Cheney; Mary E Reid; Samuel G Armato; Thomas Krausz; Aliya N Husain
Lymphatic vessel density is not associated with lymph node metastasis in non-small cell lung carcinoma.
Archives of pathology & laboratory medicine 2008;132(12):1882-8.
2008: Patrick C Ma; Maria Tretiakova; Alexander C MacKinnon; Nithya Ramnath; Candace Johnson; Sascha Dietrich; Tanguy Seiwert; James G Christensen; Ramasamy Jagadeeswaran; Thomas Krausz; Everett E Vokes; Aliya N Husain; Ravi Salgia
Expression and mutational analysis of MET in human solid cancers.
Genes, chromosomes & cancer 2008;47(12):1025-37.
2008: Leonardo Faoro; Sivakumar Loganathan; Maria Westerhoff; Rahul Modi; Aliya N Husain; Maria Tretiakova; Tanguy Seiwert; Hedy L Kindler; Everett E Vokes; Ravi Salgia
Protein kinase C beta in malignant pleural mesothelioma.
Anti-cancer drugs 2008;19(9):841-8.
2008: Nicholas W Choong; Ann M Mauer; Daniel J Haraf; Eric Lester; Philip C Hoffman; Mark F. Kozloff; Shang Lin; Janet E Dancey; Livia Szeto; Tatyana Grushko; Olufunmilayo I Olopade; Ravi Salgia; Everett E Vokes
Phase I trial of erlotinib-based multimodality therapy for inoperable stage III non-small cell lung cancer.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2008;3(9):1003-11.
2008: E C Koon; P C Ma; Ravi Salgia; W R Welch; J G Christensen; Ross S Berkowitz; S C Mok
Effect of a c-Met-specific, ATP-competitive small-molecule inhibitor SU11274 on human ovarian carcinoma cell growth, motility, and invasion.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2008;18(5):976-84.
2008: David M Jackman; Hedy L Kindler; Beow Y Yeap; Panos Fidias; Ravi Salgia; Joan Lucca; Linda K Morse; Patricia Ostler; Bruce E Johnson; Pasi A Janne
Erlotinib plus bevacizumab in previously treated patients with malignant pleural mesothelioma.
Cancer 2008;113(4):808-14.
2008: Halla S Nimeiri; Amit Oza; Robert J Morgan; Gregory Friberg; Kristen Kasza; Leonardo Faoro; Ravi Salgia; Walter M Stadler; Everett E Vokes; Gini F Fleming
Efficacy and safety of bevacizumab plus erlotinib for patients with recurrent ovarian, primary peritoneal, and fallopian tube cancer: a trial of the Chicago, PMH, and California Phase II Consortia.
Gynecologic oncology 2008;110(1):49-55.
2008: Taylor Sittler; Jun Zhou; Joosang Park; Noah K Yuen; Stefanie Sarantopoulos; Joseph Mollick; Ravi Salgia; Anita Giobbie-Hurder; Glenn Dranoff; F Stephen Hodi
Concerted potent humoral immune responses to autoantigens are associated with tumor destruction and favorable clinical outcomes without autoimmunity.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(12):3896-905.
2008: Shahid S Siddiqui; Sivakumar Loganathan; Soundararajan Krishnaswamy; Leonardo Faoro; Ramasamy Jagadeeswaran; Ravi Salgia
C. elegans as a model organism for in vivo screening in cancer: effects of human c-Met in lung cancer affect C. elegans vulva phenotypes.
Cancer biology & therapy 2008;7(6):856-63.
2008: Ravi J Menezes; Richard T Cheney; Aliya Husain; Maria Tretiakova; Gregory Loewen; Candace S Johnson; Vijayvel Jayaprakash; Kirsten B Moysich; Ravi Salgia; Mary E Reid
Vitamin D receptor expression in normal, premalignant, and malignant human lung tissue.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2008;17(5):1104-10.
2008: Gavin J Gordon; Madhubalan Mani; Gautam Maulik; Lipi Mukhopadhyay; Beow Y Yeap; Hedy L Kindler; Ravi Salgia; David J Sugarbaker; Raphael Bueno
Preclinical studies of the proteasome inhibitor bortezomib in malignant pleural mesothelioma.
Cancer chemotherapy and pharmacology 2008;61(4):549-58.
2008: Charles Rudin; Ravi Salgia; Xiaofei Wang; Lydia D Hodgson; Gregory A Masters; Mark Green; Everett E Vokes
Randomized phase II Study of carboplatin and etoposide with or without the bcl-2 antisense oligonucleotide oblimersen for extensive-stage small-cell lung cancer: CALGB 30103.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(6):870-6.
2008: Neelu Puri; Ravi Salgia
Synergism of EGFR and c-Met pathways, cross-talk and inhibition, in non-small cell lung cancer.
Journal of carcinogenesis 2008;7():9.
2008: Ravi Salgia
Stamp out lung cancer.
Journal of carcinogenesis 2008;7():7.
2008: Martin Sattler; Oyewale Abidoye; Ravi Salgia
EGFR-targeted therapeutics: focus on SCCHN and NSCLC.
TheScientificWorldJournal 2008;8():909-19.
2008: Ramasamy Jagadeeswaran; Hanna Surawska; Soundararajan Krishnaswamy; Varalakshmi Janamanchi; A Craig Mackinnon; Tanguy Y Seiwert; Sivakumar Loganathan; Rajani Kanteti; Trevor Reichman; Vidya Nallasura; Stuart Schwartz; Leonardo Faoro; Yi-Ching Wang; Luc Girard; Maria S Tretiakova; Salman Ahmed; Osvaldo Zumba; Lioubov Soulii; Vytas P Bindokas; Livia L Szeto; Gavin J Gordon; Raphael Bueno; David Sugarbaker; Mark W Lingen; Martin Sattler; Thomas Krausz; Wickii Vigneswaran; Viswanathan Natarajan; John Minna; Everett E Vokes; Mark K Ferguson; Aliya N Husain; Ravi Salgia
Paxillin is a target for somatic mutations in lung cancer: implications for cell growth and invasion.
Cancer research 2008;68(1):132-42.
2007: Olwen Hahn; Ravi Salgia
Non-receptor tyrosine kinase inhibitors in lung cancer.
Anti-cancer agents in medicinal chemistry 2007;7(6):633-42.
2007: Yutong Zhao; Donghong He; Randi Stern; Peter Usatyuk; Ernst Wm Spannhake; Ravi Salgia; Viswanathan Natarajan
Lysophosphatidic acid modulates c-Met redistribution and hepatocyte growth factor/c-Met signaling in human bronchial epithelial cells through PKC delta and E-cadherin.
Cellular signalling 2007;19(11):2329-38.
2007: Patrick A Singleton; Ravi Salgia; Liliana Moreno Vinasco; Jaideep Moitra; Saad Sammani; Tamara Mirzapoiazova; Joe G. N. Garcia
CD44 regulates hepatocyte growth factor-mediated vascular integrity. Role of c-Met, Tiam1/Rac1, dynamin 2, and cortactin.
The Journal of biological chemistry 2007;282(42):30643-57.
2007: Patrick C Ma; Maria Tretiakova; Vidya Nallasura; Ramasamy Jagadeeswaran; Aliya N Husain; Ravi Salgia
Downstream signalling and specific inhibition of c-MET/HGF pathway in small cell lung cancer: implications for tumour invasion.
British journal of cancer 2007;97(3):368-77.
2007: Arif Y Shaikh; Daniel J Haraf; Joseph K Salama; Ravi Salgia; Philip C Hoffman; Mark K Ferguson; Philip P Connell
Chemotherapy and high dose radiotherapy followed by resection for locally advanced nonsmall cell lung cancers.
American journal of clinical oncology 2007;30(3):258-63.
2007: Ramasamy Jagadeeswaran; Sujatha Jagadeeswaran; Vytautas P Bindokas; Ravi Salgia
Activation of HGF/c-Met pathway contributes to the reactive oxygen species generation and motility of small cell lung cancer cells.
American journal of physiology. Lung cellular and molecular physiology 2007;292(6):L1488-94.
2007: Oyewale Abidoye; Nadh Murukurthy; Ravi Salgia
Review of clinic trials: agents targeting c-Met.
Reviews on recent clinical trials 2007;2(2):143-7.
2007: Ajit Bharti; Patrick C Ma; Ravi Salgia
Biomarker discovery in lung cancer--promises and challenges of clinical proteomics.
Mass spectrometry reviews 2007;26(3):451-66.
2007: Neelu Puri; Andrey Khramtsov; Salman Ahmed; Vidya Nallasura; Jeremy T Hetzel; Ramasamy Jagadeeswaran; Gregory S Karczmar; Ravi Salgia
A selective small molecule inhibitor of c-Met, PHA665752, inhibits tumorigenicity and angiogenesis in mouse lung cancer xenografts.
Cancer research 2007;67(8):3529-34.
2007: Neelu Puri; Salman Ahmed; Varalakshmi Janamanchi; Maria Tretiakova; Osvaldo Zumba; Thomas Krausz; Ramasamy Jagadeeswaran; Ravi Salgia
c-Met is a potentially new therapeutic target for treatment of human melanoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(7):2246-53.
2007: Martin Sattler; Ravi Salgia
c-Met and hepatocyte growth factor: potential as novel targets in cancer therapy.
Current oncology reports 2007;9(2):102-8.
2007: Kenjiro Sawada; Amir Reza Radjabi; Nariyoshi Shinomiya; Emily O Kistner; Hilary Kenny; Amy R Becker; Muge Turkyilmaz; Ravi Salgia; S Diane Yamada; George Vande Woude; Maria Tretiakova; Ernst Lengyel
c-Met overexpression is a prognostic factor in ovarian cancer and an effective target for inhibition of peritoneal dissemination and invasion.
Cancer research 2007;67(4):1670-9.
2007: Nicholas W Choong; Ravi Salgia; Everett E Vokes
Key signaling pathways and targets in lung cancer therapy.
Clinical lung cancer 2007;8 Suppl 2():S52-60.
2007: Ernst Lengyel; Kenjiro Sawada; Ravi Salgia
Tyrosine kinase mutations in human cancer.
Current molecular medicine 2007;7(1):77-84.
2007: Oyewale Abidoye; Mark K Ferguson; Ravi Salgia
Lung carcinoma in African Americans.
Nature clinical practice. Oncology 2007;4(2):118-29.
2007: Tanguy Seiwert; Philip P Connell; Ann M Mauer; Philip C Hoffman; Christopher M George; Livia Szeto; Ravi Salgia; Katherine E Posther; Binh Nguyen; Daniel J Haraf; Everett E Vokes
A phase I study of pemetrexed, carboplatin, and concurrent radiotherapy in patients with locally advanced or metastatic non-small cell lung or esophageal cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(2 Pt 1):515-22.
2006: M Kelly Nicholas; Rimas V Lukas; Nazia F Jafri; Leonardo Faoro; Ravi Salgia
Epidermal growth factor receptor - mediated signal transduction in the development and therapy of gliomas.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(24):7261-70.
2006: Hatim Chhatriwala; Nazia Jafri; Ravi Salgia
A review of topoisomerase inhibition in lung cancer.
Cancer biology & therapy 2006;5(12):1600-7.
2006: Ravi Salgia
c-Met inhibition.
Clinical advances in hematology & oncology : H&O 2006;4(11):823-4.
2006: Syed M Ahmed; Ravi Salgia
Epidermal growth factor receptor mutations and susceptibility to targeted therapy in lung cancer.
Respirology (Carlton, Vic.) 2006;11(6):687-92.
2006: Michael L Maitland; Rebecca Wilcox; D Kyle Hogarth; Apurva A Desai; Phil Caligiuri; Cyril Abrahams; Ravi Salgia
Diffuse alveolar damage after a single dose of topotecan in a patient with pulmonary fibrosis and small cell lung cancer.
Lung cancer (Amsterdam, Netherlands) 2006;54(2):243-5.
2006: Nicholas W Choong; Sascha Dietrich; Tanguy Seiwert; Maria Tretiakova; Vidya Nallasura; Gareth C Davies; Stan Lipkowitz; Aliya N Husain; Ravi Salgia; Patrick C Ma
Gefitinib response of erlotinib-refractory lung cancer involving meninges--role of EGFR mutation.
Nature clinical practice. Oncology 2006;3(1):50-7; quiz 1 p following 57.
2006: Ramasamy Jagadeeswaran; Patrick C Ma; Tanguy Seiwert; Sujatha Jagadeeswaran; Osvaldo Zumba; Vidya Nallasura; Salman Ahmed; Rosangela Filiberti; Michela Paganuzzi; riccardo puntoni; Robert A Kratzke; Gavin J Gordon; David J Sugarbaker; Raphael Bueno; Varalakshmi Janamanchi; Vytautas P Bindokas; Hedy L Kindler; Ravi Salgia
Functional analysis of c-Met/hepatocyte growth factor pathway in malignant pleural mesothelioma.
Cancer research 2006;66(1):352-61.
2005: Evan Pisick; Ravi Salgia
Molecular biology of malignant mesothelioma: a review.
Hematology/oncology clinics of North America 2005;19(6):997-1023, v.
2005: James G Christensen; Jon Burrows; Ravi Salgia
c-Met as a target for human cancer and characterization of inhibitors for therapeutic intervention.
Cancer letters 2005;225(1):1-26.
2005: Fei Chu; John Barkinge; Sarah Hawkins; Radhika Gudi; Ravi Salgia; Prasad Vk Kanteti
Expression of Siva-1 protein or its putative amphipathic helical region enhances cisplatin-induced apoptosis in breast cancer cells: effect of elevated levels of BCL-2.
Cancer research 2005;65(12):5301-9.
2005: Nicholas W Choong; Patrick C Ma; Ravi Salgia
Therapeutic targeting of receptor tyrosine kinases in lung cancer.
Expert opinion on therapeutic targets 2005;9(3):533-59.
2005: Olwen Hahn; Ravi Salgia
Novel therapies in lung cancer.
Hematology/oncology clinics of North America 2005;19(2):343-67, vii.
2005: Patrick C Ma; Erik M Schaefer; James G Christensen; Ravi Salgia
A selective small molecule c-MET Inhibitor, PHA665752, cooperates with rapamycin.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(6):2312-9.
2005: Patrick C Ma; Ramasamy Jagadeeswaran; Simha Jagadeesh; Maria Tretiakova; Vidya Nallasura; Edward A Fox; Mark Hansen; Erik M Schaefer; Katsuhiko Naoki; Alan Lader; William Richards; David J Sugarbaker; Aliya N Husain; James G Christensen; Ravi Salgia
Functional expression and mutations of c-Met and its therapeutic inhibition with SU11274 and small interfering RNA in non-small cell lung cancer.
Cancer research 2005;65(4):1479-88.
2005: Jeong H Kim; Stephanie C Chu; Jessica L Gramlich; Yuri B Pride; Emily Babendreier; Dharminder Chauhan; Ravi Salgia; klaus podar; James D Griffin; Martin Sattler
Activation of the PI3K/mTOR pathway by BCR-ABL contributes to increased production of reactive oxygen species.
Blood 2005;105(4):1717-23.
2004: Hanna Surawska; Patrick C Ma; Ravi Salgia
The role of ephrins and Eph receptors in cancer.
Cytokine & growth factor reviews 2004;15(6):419-33.
2004: Evan Pisick; Simha Jagadeesh; Ravi Salgia
Receptor tyrosine kinases and inhibitors in lung cancer.
TheScientificWorldJournal 2004;4():589-604.
2004: Nishit K Mukhopadhyay; David Gilchrist; Gavin J Gordon; Chang-Jie Chen; Raphael Bueno; Michael L Lu; Ravi Salgia; David J Sugarbaker; Michael T Jaklitsch
Integrin-dependent protein tyrosine phosphorylation is a key regulatory event in collagen-IV-mediated adhesion and proliferation of human lung tumor cell line, Calu-1.
The Annals of thoracic surgery 2004;78(2):450-7.
2004: N Jafri; Ravi Salgia
Biology and novel therapeutics for neuroendocrine tumors of the lung.
Journal of biological regulators and homeostatic agents 2004;18(3-4):275-90.
2004: Stine-Kathrein Kraeft; Andras Ladanyi; Kevin Galiger; Anna Herlitz; Andrew C Sher; Danielle E Bergsrud; Gaelle Even; Stephanie Brunelle; Lyndsay Harris; Ravi Salgia; Tom Dahl; John Kesterson; Lan Bo Chen
Reliable and sensitive identification of occult tumor cells using the improved rare event imaging system.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(9):3020-8.
2004: Martin Sattler; Ravi Salgia
Targeting c-Kit mutations: basic science to novel therapies.
Leukemia research 2004;28 Suppl 1():S11-20.
2004: Patrick C Ma; Ravi Salgia
Novel targets for therapeutic agents in small cell lung cancer.
Journal of the National Comprehensive Cancer Network : JNCCN 2004;2(2):165-72.
2004: Ajit Bharti; Patrick C Ma; Gautam Maulik; Rajeev Singh; Ehsan Khan; Arthur T Skarin; Ravi Salgia
Haptoglobin alpha-subunit and hepatocyte growth factor can potentially serve as serum tumor biomarkers in small cell lung cancer.
Anticancer research 2004;24(2C):1031-8.
2004: Nevin Murray; Ravi Salgia; Frank V Fossella
Targeted molecules in small cell lung cancer.
Seminars in oncology 2004;31(1 Suppl 1):106-11.
2004: Gautam Maulik; Ajit Bharti; Ehsan Khan; Ryan J Broderick; Takashi Kijima; Ravi Salgia
Modulation of c-Kit/SCF pathway leads to alterations in topoisomerase-I activity in small cell lung cancer.
Journal of environmental pathology, toxicology and oncology : official organ of the International Society for Environmental Toxicology and Cancer 2004;23(4):237-51.
2004: Martin Sattler; Patrick C Ma; Ravi Salgia
Therapeutic targeting of the receptor tyrosine kinase Met.
Cancer treatment and research 2004;119():121-38.
2003: Bruce E Johnson; Thomas Fischer; Berthold Fischer; David Dunlop; Danny Rischin; Sandra Silberman; Mildred Ortu Kowalski; Deanne Sayles; Sasa Dimitrijevic; Christopher Fletcher; Jason Hornick; Ravi Salgia; Thierry Le Chevalier
Phase II study of imatinib in patients with small cell lung cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(16 Pt 1):5880-7.
2003: Patrick C Ma; Gautam Maulik; James Christensen; Ravi Salgia
c-Met: structure, functions and potential for therapeutic inhibition.
Cancer metastasis reviews 2003;22(4):309-25.
2003: Evan Pisick; Simha Jagadeesh; Ravi Salgia
Small cell lung cancer: from molecular biology to novel therapeutics.
Journal of experimental therapeutics & oncology 2003;3(6):305-18.
2003: Patrick C Ma; Takashi Kijima; Gautam Maulik; Edward A Fox; Martin Sattler; James D Griffin; Bruce E Johnson; Ravi Salgia
c-MET mutational analysis in small cell lung cancer: novel juxtamembrane domain mutations regulating cytoskeletal functions.
Cancer research 2003;63(19):6272-81.
2003: Martin Sattler; Yuri B Pride; Patrick Ma; Jessica L Gramlich; Stephanie C Chu; Laura A Quinnan; Sheri Shirazian; Congxin Liang; klaus podar; James G Christensen; Ravi Salgia
A novel small molecule met inhibitor induces apoptosis in cells transformed by the oncogenic TPR-MET tyrosine kinase.
Cancer research 2003;63(17):5462-9.
2003: Evan Pisick; Arthur T Skarin; Ravi Salgia
Recent advances in the molecular biology, diagnosis and novel therapies for various small blue cell tumors.
Anticancer research 2003;23(4):3379-96.
2003: Martin Sattler; Laura R Quinnan; Yuri B Pride; Jessica L Gramlich; Stephanie C Chu; Gaelle C Even; Stine-Katherin Kraeft; Lan Bo Chen; Ravi Salgia
2-methoxyestradiol alters cell motility, migration, and adhesion.
Blood 2003;102(1):289-96.
2003: Jennifer R Brown; Tad J Wieczorek; Kitt Shaffer; Ravi Salgia
Small-cell cancers, and an unusual reaction to chemotherapy. Case 1. Extrapulmonary small-cell carcinoma arising in the prostate.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(12):2437-8.
2003: Hanna Yoko Irie; Michael T Jaklitsch; Kitt Shaffer; Michael Weinstein; Ravi Salgia
Unusual problems in breast cancer and a rare lung cancer case. Case 4. Primary lymphoepithelioma-like carcinoma of the lung.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(11):2220-2.
2003: Takashi Kijima; Gautam Maulik; Patrick C Ma; Priya Madhiwala; Erik M Schaefer; Ravi Salgia
Fibronectin enhances viability and alters cytoskeletal functions (with effects on the phosphatidylinositol 3-kinase pathway) in small cell lung cancer.
Journal of cellular and molecular medicine 2003;7(2):157-64.
2003: Ravi Salgia; Arthur T Skaring
p53 and Bcl-2 in small cell-lung cancer.
Clinical lung cancer 2003;4(5):303.
2003: Ravi Salgia; Thomas J Lynch; Arthur T Skarin; Joan Lucca; Cathy Lynch; Ken Jung; F Stephen Hodi; Michael T Jaklitsch; Steven J Mentzer; Scott Swanson; Jeanne M Lukanich; Raphael Bueno; John Wain; Douglas J Mathisen; Cameron Wright; Panos Fidias; Dean Donahue; Shirley Clift; Steve Hardy; Donna Neuberg; Richard Mulligan; Iain Webb; David J Sugarbaker; Martin Mihm; Glenn Dranoff
Vaccination with irradiated autologous tumor cells engineered to secrete granulocyte-macrophage colony-stimulating factor augments antitumor immunity in some patients with metastatic non-small-cell lung carcinoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(4):624-30.
2003: Martin Sattler; Ravi Salgia
Molecular and cellular biology of small cell lung cancer.
Seminars in oncology 2003;30(1):57-71.
2003: Nazia F Jafri; Patrick C Ma; Gautam Maulik; Ravi Salgia
Mechanisms of metastasis as related to receptor tyrosine kinases in small-cell lung cancer.
Journal of environmental pathology, toxicology and oncology : official organ of the International Society for Environmental Toxicology and Cancer 2003;22(3):147-65.
2003: Martin Sattler; Elizabeth Quackenbush; Ravi Salgia
Cell motility, adhesion, homing, and migration assays in the studies of tyrosine kinases.
Methods in molecular medicine 2003;85():87-105.
2003: Patrick C Ma; Lawrence S Blaszkowsky; Ajit Bharti; Andras Ladanyi; Stine-Kathrein Kraeft; Adam Bruno; Arthur T Skarin; Lan Bo Chen; Ravi Salgia
Circulating tumor cells and serum tumor biomarkers in small cell lung cancer.
Anticancer research 2003;23(1A):49-62.
2003: Benjamin L Ebert; Ewa Niemierko; Kitt Shaffer; Ravi Salgia
Use of temozolomide with other cytotoxic chemotherapy in the treatment of patients with recurrent brain metastases from lung cancer.
The oncologist 2003;8(1):69-75.
2003: Gautam Maulik; Takashi Kijima; Ravi Salgia
Role of receptor tyrosine kinases in lung cancer.
Methods in molecular medicine 2003;74():113-25.
2003: Stine-Kathrein Kraeft; Ravi Salgia; Lan Bo Chen
Detection and analysis of lung cancer cells from body fluids using a rare event imaging system.
Methods in molecular medicine 2003;75():423-30.
2003: Takashi Kijima; Gautam Maulik; Ravi Salgia
Molecular alterations in lung cancer. Impact on prognosis.
Methods in molecular medicine 2003;75():29-38.
2002: Takashi Kijima; Gautam Maulik; Patrick C Ma; Elena V Tibaldi; Ross E Turner; Barrett J Rollins; Martin Sattler; Bruce E Johnson; Ravi Salgia
Regulation of cellular proliferation, cytoskeletal function, and signal transduction through CXCR4 and c-Kit in small cell lung cancer cells.
Cancer research 2002;62(21):6304-11.
2002: Gautam Maulik; P Madhiwala; S Brooks; Patrick C Ma; Takashi Kijima; Elena V Tibaldi; Erik M Schaefer; Kalindi Parmar; Ravi Salgia
Activated c-Met signals through PI3K with dramatic effects on cytoskeletal functions in small cell lung cancer.
Journal of cellular and molecular medicine 2002;6(4):539-53.
2002: Pasi A Janne; Michele L Taffaro; Ravi Salgia; Bruce E Johnson
Inhibition of epidermal growth factor receptor signaling in malignant pleural mesothelioma.
Cancer research 2002;62(18):5242-7.
2002: Shouchun Liu; William B Kiosses; David M Rose; Marina Slepak; Ravi Salgia; James D Griffin; Christopher E Turner; Martin A Schwartz; Mark H Ginsberg
A fragment of paxillin binds the alpha 4 integrin cytoplasmic domain (tail) and selectively inhibits alpha 4-mediated cell migration.
The Journal of biological chemistry 2002;277(23):20887-94.
2002: Melenda Jeter; Pasi A Janne; Sarah Brooks; Harold J Burstein; Patrick Y Wen; Charlie S Fuchs; Jay S Loeffler; Phillip M Devlin; Ravi Salgia
Gemcitabine-induced radiation recall.
International journal of radiation oncology, biology, physics 2002;53(2):394-400.
2002: Elena V Tibaldi; Ravi Salgia; Ellis L Reinherz
CD2 molecules redistribute to the uropod during T cell scanning: implications for cellular activation and immune surveillance.
Proceedings of the National Academy of Sciences of the United States of America 2002;99(11):7582-7.
2002: F Stephen Hodi; Jan C Schmollinger; Robert J Soiffer; Ravi Salgia; Thomas J Lynch; Jerome Ritz; Edwin P Alyea; Jihong Yang; Donna Neuberg; Martin Mihm; Glenn Dranoff
ATP6S1 elicits potent humoral responses associated with immune-mediated tumor destruction.
Proceedings of the National Academy of Sciences of the United States of America 2002;99(10):6919-24.
2002: klaus podar; Yu-Tzu Tai; Boris K Lin; Radha P Narsimhan; Martin Sattler; Takashi Kijima; Ravi Salgia; Deepak Gupta; Dharminder Chauhan; Kenneth C Anderson
Vascular endothelial growth factor-induced migration of multiple myeloma cells is associated with beta 1 integrin- and phosphatidylinositol 3-kinase-dependent PKC alpha activation.
The Journal of biological chemistry 2002;277(10):7875-81.
2002: Martin Sattler; Yuri B Pride; Laura R Quinnan; Shalini Verma; Nicole A Malouf; Hervé Husson; Ravi Salgia; Stanley Lipkowitz; James D Griffin
Differential expression and signaling of CBL and CBL-B in BCR/ABL transformed cells.
Oncogene 2002;21(9):1423-33.
2002: Gautam Maulik; Takashi Kijima; Patrick C Ma; Sudip Ghosh; Jeffrey Lin; Geoffrey I Shapiro; Erik M Schaefer; Elena V Tibaldi; Bruce E Johnson; Ravi Salgia
Modulation of the c-Met/hepatocyte growth factor pathway in small cell lung cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2002;8(2):620-7.
2002: Gautam Maulik; Amol Shrikhande; Takashi Kijima; Patrick C Ma; Paul Morrison; Ravi Salgia
Role of the hepatocyte growth factor receptor, c-Met, in oncogenesis and potential for therapeutic inhibition.
Cytokine & growth factor reviews 2002;13(1):41-59.
2002: Gautam Maulik; Ravi Salgia; Michael G Makrigiorgos
Flow cytometric determination of lipid peroxidation using fluoresceinated phosphoethanolamine.
Methods in enzymology 2002;352():80-91.
2001: R S Herbst; C Lynch; M Vasconcelles; B A Teicher; G Strauss; A Elias; I Anderson; P Zacarola; N H Dang; T Leong; Ravi Salgia; Arthur T Skarin
Gemcitabine and vinorelbine in patients with advanced lung cancer: preclinical studies and report of a phase I trial.
Cancer chemotherapy and pharmacology 2001;48(2):151-9.
2001: Ravi Salgia; D Harpole; J E Herndon; Evan Pisick; A Elias; Arthur T Skarin
Role of serum tumor markers CA 125 and CEA in non-small cell lung cancer.
Anticancer research 2001;21(2B):1241-6.
2001: B P Rubin; Arthur T Skarin; Evan Pisick; M Rizk; Ravi Salgia
Use of cytokeratins 7 and 20 in determining the origin of metastatic carcinoma of unknown primary, with special emphasis on lung cancer.
European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP) 2001;10(1):77-82.
2001: Martin Sattler; Shalini Verma; Yuri B Pride; Ravi Salgia; L R Rohrschneider; James D Griffin
SHIP1, an SH2 domain containing polyinositol-5-phosphatase, regulates migration through two critical tyrosine residues and forms a novel signaling complex with DOK1 and CRKL.
The Journal of biological chemistry 2001;276(4):2451-8.
2000: Ricardo Aguiar; Y Yakushijin; S Kharbanda; Ravi Salgia; J A Fletcher; Margaret A Shipp
BAL is a novel risk-related gene in diffuse large B-cell lymphomas that enhances cellular migration.
Blood 2000;96(13):4328-34.
2000: Martin Sattler; Shalini Verma; G Shrikhande; CH Byrne; Yuri B Pride; Thomas Winkler; Edward Greenfield; Ravi Salgia; James D Griffin
The BCR/ABL tyrosine kinase induces production of reactive oxygen species in hematopoietic cells.
The Journal of biological chemistry 2000;275(32):24273-8.
2000: W L Wang; M E Healy; Martin Sattler; Shalini Verma; J Lin; Gautam Maulik; Charles D Stiles; James D Griffin; Bruce E Johnson; Ravi Salgia
Growth inhibition and modulation of kinase pathways of small cell lung cancer cell lines by the novel tyrosine kinase inhibitor STI 571.
Oncogene 2000;19(31):3521-8.
2000: G Venkatakrishnan; Ravi Salgia; Jerome E Groopman
Chemokine receptors CXCR-1/2 activate mitogen-activated protein kinase via the epidermal growth factor receptor in ovarian cancer cells.
The Journal of biological chemistry 2000;275(10):6868-75.
2000: Y Shen; P Lyons; M Cooley; D Davidson; A Veillette; Ravi Salgia; James D Griffin; Michael D Schaller
The noncatalytic domain of protein-tyrosine phosphatase-PEST targets paxillin for dephosphorylation in vivo.
The Journal of biological chemistry 2000;275(2):1405-13.
2000: Martin Sattler; Evan Pisick; Paul Morrison; Ravi Salgia
Role of the cytoskeletal protein paxillin in oncogenesis.
Critical reviews in oncogenesis 2000;11(1):63-76.
2000: M Galsky; M Darling; J Hecht; Ravi Salgia
Case 1: small bowel obstruction due to metastatic lung cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(1):227-8.
1999: J W Thomas; M A Cooley; J M Broome; Ravi Salgia; James D Griffin; C R Lombardo; Michael D Schaller
The role of focal adhesion kinase binding in the regulation of tyrosine phosphorylation of paxillin.
The Journal of biological chemistry 1999;274(51):36684-92.
1999: Ravi Salgia; Elizabeth J Quackenbush; J Lin; N Souchkova; Martin Sattler; DS Ewaniuk; KM Klucher; George Q Daley; S K Kraeft; R Sackstein; Edwin P Alyea; Ulrich H von Andrian; Lan Bo Chen; Jose-Carlos Gutierrez-Ramos; A M Pendergast; James D Griffin
The BCR/ABL oncogene alters the chemotactic response to stromal-derived factor-1alpha.
Blood 1999;94(12):4233-46.
1999: Y Sun; J Zhang; Stine-Kathrein Kraeft; Daniel Auclair; M S Chang; Y Liu; R Sutherland; Ravi Salgia; James D Griffin; LH Ferland; Lan Bo Chen
Molecular cloning and characterization of human trabeculin-alpha, a giant protein defining a new family of actin-binding proteins.
The Journal of biological chemistry 1999;274(47):33522-30.
1999: N Uemura; Ravi Salgia; DS Ewaniuk; M T Little; James D Griffin
Involvement of the adapter protein CRKL in integrin-mediated adhesion.
Oncogene 1999;18(22):3343-53.
1999: Martin Sattler; Thomas Winkler; Shalini Verma; CH Byrne; G Shrikhande; Ravi Salgia; James D Griffin
Hematopoietic growth factors signal through the formation of reactive oxygen species.
Blood 1999;93(9):2928-35.
1999: Ravi Salgia; J L Li; DS Ewaniuk; Y B Wang; Martin Sattler; W C Chen; W Richards; Evan Pisick; Geoffrey I Shapiro; Barrett J Rollins; Lan Bo Chen; James D Griffin; D J Sugarbaker
Expression of the focal adhesion protein paxillin in lung cancer and its relation to cell motility.
Oncogene 1999;18(1):67-77.
1998: J Li; K Nishizawa; W An; Rebecca E Hussey; F E Lialios; Ravi Salgia; R Sunder-Plassmann; Ellis L Reinherz
A cdc15-like adaptor protein (CD2BP1) interacts with the CD2 cytoplasmic domain and regulates CD2-triggered adhesion.
The EMBO journal 1998;17(24):7320-36.
1998: Ravi Salgia; T R Hedges; M Rizk; R H Reimer; Arthur T Skarin
Cancer-associated retinopathy in a patient with non-small-cell lung carcinoma.
Lung cancer (Amsterdam, Netherlands) 1998;22(2):149-52.
1998: Martin Sattler; Ravi Salgia
Role of the adapter protein CRKL in signal transduction of normal hematopoietic and BCR/ABL-transformed cells.
Leukemia 1998;12(5):637-44.
1998: Ravi Salgia; Arthur T Skarin
Molecular abnormalities in lung cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(3):1207-17.
1997: X Tong; Ravi Salgia; J L Li; James D Griffin; Peter M Howley
The bovine papillomavirus E6 protein binds to the LD motif repeats of paxillin and blocks its interaction with vinculin and the focal adhesion kinase.
The Journal of biological chemistry 1997;272(52):33373-6.
1997: Anne L Astier; SN Manié; SF Law; Timothy Canty; N Haghayghi; Brian J Druker; Ravi Salgia; Erica A Golemis; Arnold S Freedman
Association of the Cas-like molecule HEF1 with CrkL following integrin and antigen receptor signaling in human B-cells: potential relevance to neoplastic lymphohematopoietic cells.
Leukemia & lymphoma 1997;28(1-2):65-72.
1997: Martin Sattler; Ravi Salgia; G Shrikhande; Shalini Verma; J L Choi; Larry R Rohrschneider; James D Griffin
The phosphatidylinositol polyphosphate 5-phosphatase SHIP and the protein tyrosine phosphatase SHP-2 form a complex in hematopoietic cells which can be regulated by BCR/ABL and growth factors.
Oncogene 1997;15(19):2379-84.
1997: Ravi Salgia; J L Li; DS Ewaniuk; W Pear; Evan Pisick; S A Burky; T Ernst; Martin Sattler; Lan Bo Chen; James D Griffin
BCR/ABL induces multiple abnormalities of cytoskeletal function.
The Journal of clinical investigation 1997;100(1):46-57.
1997: Martin Sattler; Ravi Salgia; G Shrikhande; Shalini Verma; N Uemura; SF Law; Erica A Golemis; James D Griffin
Differential signaling after beta1 integrin ligation is mediated through binding of CRKL to p120(CBL) and p110(HEF1).
The Journal of biological chemistry 1997;272(22):14320-6.
1997: Martin Sattler; Ravi Salgia; G Shrikhande; Shalini Verma; Evan Pisick; Kanteti V Prasad; James D Griffin
Steel factor induces tyrosine phosphorylation of CRKL and binding of CRKL to a complex containing c-kit, phosphatidylinositol 3-kinase, and p120(CBL).
The Journal of biological chemistry 1997;272(15):10248-53.
1997: Martin Sattler; Ravi Salgia; M A Durstin; Kanteti V Prasad; James D Griffin
Thrombopoietin induces activation of the phosphatidylinositol-3' kinase pathway and formation of a complex containing p85PI3K and the protooncoprotein p120CBL.
Journal of cellular physiology 1997;171(1):28-33.
1997: Martin Sattler; Ravi Salgia
Activation of hematopoietic growth factor signal transduction pathways by the human oncogene BCR/ABL.
Cytokine & growth factor reviews 1997;8(1):63-79.
1997: N Uemura; Ravi Salgia; J L Li; Evan Pisick; Martin Sattler; James D Griffin
The BCR/ABL oncogene alters interaction of the adapter proteins CRKL and CRK with cellular proteins.
Leukemia 1997;11(3):376-85.
1997: SN Manié; A R Beck; Anne L Astier; SF Law; Timothy Canty; H Hirai; Brian J Druker; Hava Karsenty Avraham; N Haghayeghi; Martin Sattler; Ravi Salgia; James D Griffin; Erica A Golemis; Arnold S Freedman
Involvement of p130(Cas) and p105(HEF1), a novel Cas-like docking protein, in a cytoskeleton-dependent signaling pathway initiated by ligation of integrin or antigen receptor on human B cells.
The Journal of biological chemistry 1997;272(7):4230-6.
1997: E Weisberg; Martin Sattler; DS Ewaniuk; Ravi Salgia
Role of focal adhesion proteins in signal transduction and oncogenesis.
Critical reviews in oncogenesis 1997;8(4):343-58.
1997: SN Manié; Martin Sattler; Anne L Astier; J S Phifer; Timothy Canty; Chikao Morimoto; Brian J Druker; Ravi Salgia; James D Griffin; Arnold S Freedman
Tyrosine phosphorylation of the product of the c-cbl protooncogene is [corrected] induced after integrin stimulation.
Experimental hematology 1997;25(1):45-50.
1996: Ravi Salgia; S Avraham; Evan Pisick; J L Li; S Raja; Edward Greenfield; Martin Sattler; Hava Karsenty Avraham; James D Griffin
The related adhesion focal tyrosine kinase forms a complex with paxillin in hematopoietic cells.
The Journal of biological chemistry 1996;271(49):31222-6.
1996: Ravi Salgia; Evan Pisick; Martin Sattler; J L Li; N Uemura; W K Wong; S A Burky; H Hirai; Lan Bo Chen; James D Griffin
p130CAS forms a signaling complex with the adapter protein CRKL in hematopoietic cells transformed by the BCR/ABL oncogene.
The Journal of biological chemistry 1996;271(41):25198-203.
1996: Martin Sattler; Ravi Salgia; K Okuda; N Uemura; M A Durstin; Evan Pisick; G Xu; J L Li; Kanteti V Prasad; James D Griffin
The proto-oncogene product p120CBL and the adaptor proteins CRKL and c-CRK link c-ABL, p190BCR/ABL and p210BCR/ABL to the phosphatidylinositol-3' kinase pathway.
Oncogene 1996;12(4):839-46.
1996: Ravi Salgia; Martin Sattler; Evan Pisick; J L Li; James D Griffin
p210BCR/ABL induces formation of complexes containing focal adhesion proteins and the protooncogene product p120c-Cbl.
Experimental hematology 1996;24(2):310-3.
1995: Ravi Salgia; N Uemura; K Okuda; J L Li; Evan Pisick; Martin Sattler; Ron de Jong; Brian J Druker; N Heisterkamp; Lan Bo Chen
CRKL links p210BCR/ABL with paxillin in chronic myelogenous leukemia cells.
The Journal of biological chemistry 1995;270(49):29145-50.
1995: Ravi Salgia; B Brunkhorst; Evan Pisick; J L Li; Su Hao Lo; Lan Bo Chen; James D Griffin
Increased tyrosine phosphorylation of focal adhesion proteins in myeloid cell lines expressing p210BCR/ABL.
Oncogene 1995;11(6):1149-55.
1995: Martin Sattler; M A Durstin; David A Frank; K Okuda; K Kaushansky; Ravi Salgia; James D Griffin
The thrombopoietin receptor c-MPL activates JAK2 and TYK2 tyrosine kinases.
Experimental hematology 1995;23(9):1040-8.
1995: A Chakravarty; Ravi Salgia; E Mason; R Rajendran; P Muthuswamy
Pneumonia and infraorbital abscess in a 29-year-old diabetic pregnant woman.
Chest 1995;107(6):1752-4.
1995: Ravi Salgia; J L Li; Su Hao Lo; B Brunkhorst; Geoffrey S Kansas; E S Sobhany; YanPing Sun; Evan Pisick; Michael Hallek; T Ernst
Molecular cloning of human paxillin, a focal adhesion protein phosphorylated by P210BCR/ABL.
The Journal of biological chemistry 1995;270(10):5039-47.
1994: K Okuda; Ursula Matulonis; Ravi Salgia; Y Kanakura; Brian J Druker; James D Griffin
Factor independence of human myeloid leukemia cell lines is associated with increased phosphorylation of the proto-oncogene Raf-1.
Experimental hematology 1994;22(11):1111-7.
1994: Ravi Salgia; George D Demetri; W D Kaplan
Changes in Tc-99m radionuclide bone scan images and peripheralization of marrow hematopoietic activity associated with the administration of granulocyte colony stimulating factor as an adjunct to dose-intensified chemotherapy for breast cancer. A case report.
Cancer 1994;74(7):1887-90.
1994: T Matsuguchi; Ravi Salgia; Michael Hallek; Matthias Eder; Brian J Druker; T J Ernst; James D Griffin
Shc phosphorylation in myeloid cells is regulated by granulocyte macrophage colony-stimulating factor, interleukin-3, and steel factor and is constitutively increased by p210BCR/ABL.
The Journal of biological chemistry 1994;269(7):5016-21.
1993: Ursula Matulonis; Ravi Salgia; K Okuda; Brian J Druker; James D Griffin
Interleukin-3 and p210 BCR/ABL activate both unique and overlapping pathways of signal transduction in a factor-dependent myeloid cell line.
Experimental hematology 1993;21(11):1460-6.
1993: Ravi Salgia; J H Becker; M M Sayeed
Altered membrane fluidity in rat hepatocytes during endotoxic shock.
Molecular and cellular biochemistry 1993;121(2):143-8.
1992: Brian J Druker; K Okuda; Ursula Matulonis; Ravi Salgia; Thomas M Roberts; James D Griffin
Tyrosine phosphorylation of rasGAP and associated proteins in chronic myelogenous leukemia cell lines.
Blood 1992;79(9):2215-20.
1989: J R Bartholomew; Ravi Salgia; W R Bell
Control of bleeding in patients with immune and nonimmune thrombocytopenia with aminocaproic acid.
Archives of internal medicine 1989;149(9):1959-61.
1987: Sucha Nand; Susan G Fisher; Ravi Salgia; Richard I Fisher
Hemostatic abnormalities in untreated cancer: incidence and correlation with thrombotic and hemorrhagic complications.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1987;5(12):1998-2003.
1987: S Buktenica; S J Olenick; Ravi Salgia; A Frankfater
Degradation and regurgitation of extracellular proteins by cultured mouse peritoneal macrophages and baby hamster kidney fibroblasts. Kinetic evidence that the transfer of proteins to lysosomes is not irreversible.
The Journal of biological chemistry 1987;262(20):9469-76.
1986: M Saito; Ravi Salgia; R Beckley; A Rosenberg
The effects of monensin on membrane lipids of cultured human skin fibroblasts.
Biochimica et biophysica acta 1986;856(3):689-93.